Type 1 Plasminogen Activator Inhibitor Induces Multimerization of Plasma Vitronectin
Open Access
- 1 November 1996
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (47), 29644-29651
- https://doi.org/10.1074/jbc.271.47.29644
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evidence that conformational changes upon the transition of the native to the modified form of vitronectin are not limited to the heparin binding domainFEBS Letters, 1995
- Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membraneBlood, 1994
- Binding and processing of multimeric vitronectin by vascular endothelial cells.Journal of Histochemistry & Cytochemistry, 1993
- Structure and Biological Role of VitronectinAnnual Review of Cell Biology, 1991
- Regulation of PAI-1 gene expressionFibrinolysis, 1991
- A novel β-endorphin binding proteinPublished by Elsevier ,1989
- Vitronectin exists in two structurally and functionally distinct forms in human plasmaBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with ureaBlood, 1988
- Novel purification of vitronectin from human plasma by heparin affinity chromatography.Cell Structure and Function, 1988
- Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol groupBiochemistry, 1985